Medicine detail

Imatinib mesylate

Used for: Imatinib mesylate is a kinase inhibitor indicated for the treatment of: • Newly diagnosed adult and pediatric patients with Philadelphia chromosome positive chronic myeloid leukemia (Ph+ CML) in chronic phase ( 1.1 ) • Patients with Philadelphia chromosome positive chronic myeloid leukemia (Ph+ CML) in blast crisis (BC), accelerated phase (AP), or in chronic phase (CP) after failure of interferon-alpha therapy ( 1.2 ) • Adult patients with relapsed or refractory Philadelphia chromosome positive acute lymphobl.

Catalog search
Imported medicine concept Imported reference ID 1854
imatinib mesylate reference image: A weekly medication organizer with capsules.
Image: Pilulier semainier.JPG by Stephane8888, CC BY-SA 2.5.
What It Is Used For

Used for: Imatinib mesylate is a kinase inhibitor indicated for the treatment of: • Newly diagnosed adult and pediatric patients with Philadelphia chromosome positive chronic myeloid leukemia (Ph+ CML) in chronic phase ( 1.1 ) • Patients with Philadelphia chromosome positive chronic myeloid leukemia (Ph+ CML) in blast crisis (BC), accelerated phase (AP), or in chronic phase (CP) after failure of interferon-alpha therapy ( 1.2 ) • Adult patients with relapsed or refractory Philadelphia chromosome positive acute lymphobl.

openFDA drug label
Active Ingredient

IMATINIB MESYLATE

Chemical Name

IMATINIB MESYLATE

Common Brands

Imatinib Mesylate

Generic / Alternate Names

IMATINIB MESYLATE

Tracking Note

Use this entry as a reference/search starting point; verify dose, indication, and safety details with official labeling or a clinician.